Industry Profile
mRNA Therapeutics
Target researchers — RNA biologists, biochemists, and drug delivery scientists with expertise in mRNA sequence optimization, 5-prime cap analogues, lipid nanoparticle formulation, innate immune evasion, and manufacturing of nucleic acid therapeutics
mRNA therapeutics harness synthetic messenger RNA to encode proteins from vaccine antigens to intracellular enzymes, enabling rapid development cycles and personalized dosing. Lipid nanoparticle delivery chemistry, cap analogue chemistry, and nucleoside modification are the key academic IP generators the industry actively licenses.
Use Cases
LNP formulation licensing
mRNA sequence optimization consulting
RNA modification technology transfer
Cold-chain logistics partnerships
Analytical characterization services
GMP RNA synthesis outsourcing
Free to browse · subscribe to unlock the full dataset
See the full dataset.
Create a free account to search every researcher, set alerts, and export verified contacts to CSV / API.
Sign Up Free →